z-logo
open-access-imgOpen Access
MicroRNAs association with azoospermia, oligospermia, asthenozoospermia, and teratozoospermia: a systematic review
Author(s) -
Yousef Daneshmandpour,
Zahra Bahmanpour,
Hamid Hamzeiy,
Marziyeh Mazaheri Moghaddam,
Madiheh Mazaheri Moghaddam,
Bahareh Khademi,
Ebrahim Sakhinia
Publication year - 2020
Publication title -
journal of assisted reproduction and genetics
Language(s) - English
Resource type - Journals
eISSN - 1573-7330
pISSN - 1058-0468
DOI - 10.1007/s10815-019-01674-9
Subject(s) - asthenozoospermia , azoospermia , male infertility , oligospermia , biology , sperm , sperm motility , infertility , andrology , bioinformatics , genetics , medicine , pregnancy
Infertility is a major health problem across the world. One of the main reasons for male infertility are defects in sperm. Semen analysis is the most common test utilized to evaluate male fertility and since it suffers from multiple drawbacks, reproduction scientists have tried to find new molecular markers for detecting sperm defects. MicroRNAs (miRNAs) are small molecules in cells which take part in regulating gene expression. Various studies have confirmed miRNAs to have a role in defining multiple sperm characteristics, including sperm count, motility, and morphology. In this paper, we have systematically reviewed the role of miRNAs in infertile men with sperm defects including azoospermia, oligospermia, asthenozoospermia, and teratozoospermia. Also, we have assembled various bioinformatics tools to come up with a pipeline for predicting novel miRNAs which could possibly participate in sperm count, motility, and morphology. Also, related KEGG and GO terms for predicted miRNAs have been included in order to highlight their role in sperm function. Our study emphasizes the potential role of miRNAs in male infertility and provides a general overview for future studies aiming to find robust molecular markers for this condition.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here